通过孟德尔随机化和网络药理学探索SLE的潜在药物标
Yanan Xu1, Zelin Wang1, Tiewen Jia1
1Department of Laboratory, The Second Hospital of Shanxi Medical University, Taiyuan, Shanxi, P.R. China.
PloS one
|January 17, 2025
概括
系统性红斑狼 (SLE) 的新型药物标被使用孟德尔随机化确定. 循环PPP3CA;PPPP3R1水平因果影响SLE风险,建议潜在的治疗策略和支持Voclosporin.
科学领域:
- 遗传学和免疫学 遗传学和免疫学
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
背景情况:
- 系统性红斑狼 (SLE) 是一种复杂的自身免疫性疾病,具有未满足的治疗需求.
- 目前的SLE治疗方法不足,并且患者之间存在很大的差异.
- 开发用于SLE的新药标是至关重要的.
研究的目的:
- 通过使用孟德尔随机化 (MR) 来识别SLE的新药标.
- 调查蛋白质水平与SLE风险之间的因果关系.
- 评估已识别的标和药物的潜力,如Voclosporin用于SLE治疗.
主要方法:
- 孟德尔的随机化分析利用来自GWAS的蛋白质定量特征位点 (pQTL).
- 脑脊液 (CSF) 和血蛋白数据的分析.
- 双向MR,局部化,表型扫描,外部数据验证,网络药理学和分子对接.
主要成果:
- 确定了ICAM-1,sICAM-1,FCG2B和PPP3CA;PPP3R1作为潜在的药物目标.
- 在排除混因素后,PPP3CA;PPP3R1被证实是SLE的新药标.
- 沃克洛斯波林和环素通过分子对接显示出与已识别的SLE标具有良好的亲和力.
结论:
- 循环的PPP3CA;PPP3R1水平对SLE风险有因果作用,是潜在的治疗点.
- 这项研究提供了证据支持Voclosporin作为潜在的SLE治疗.
- 对于PPP3CA,PPP3R1向疗法的进一步临床研究是有必要的.
相关概念视频
01:26Drug Discovery: Overview
7.4K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.4K
01:28Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493
02:26Protein Networks
3.9K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
3.9K
01:26Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K